AGP Executive Report
Last update: 3 hours agoDrug Enforcement: Irish Gardaí arrested a man after a €1.67m herbal cannabis seizure in Cork, with the drugs sent to Forensic Science Ireland for analysis. Cancer Care: A new breast-cancer-in-young-women push argues diagnosis and treatment must reflect age-linked biology, not one-size-fits-all assumptions. Biotech & Trials: Oragenics says all Australian Phase IIa sites are now active for ONP-002 in mTBI, while Prilenia and Ferreri begin the confirmatory PRECISE-HD Phase 3 study for pridopidine in Huntington’s disease. AI in Drug Discovery: Absentia Labs’ digital liver model was accepted into the FDA’s Drug Development Tool Qualification Program, aiming to cut DILI risk and drug attrition. Semiconductors & Identity: Trust Stamp joins the EU’s IPCEI AST semiconductor initiative to support privacy-first device-to-human identity for trusted hardware access. Defense Tech: AZ IMEX launched BALOR, a directed-energy counter-UAS laser defense platform for Ukraine and allied markets. Climate & Health: South Korea reports rising jellyfish and shark sightings tied to warming seas, raising risks for swimmers and fisheries. Space: Firefly Aerospace won a $13m NASA JPL subcontract to build a Mars SkyFall aeroshell for a late-2028 launch.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
